DOI QR코드

DOI QR Code

Prevalence of Osteoporosis and Effectiveness of Screening Test Using Ultrasound Bone Densitometry and Education in a Community-Dwelling Population

  • Kwon, Yu-Jun (Department of Orthopaedic Surgery, Chung-Ang University College of Medicine) ;
  • Park, Ki Soo (Department of Preventive Medicine and Institute of Health Sciences, Gyeongsang National University) ;
  • Choi, Bong Hoi (Department of Nuclear Medicine and Molecular Imaging, Gyeongsang National University) ;
  • Kim, Byung-Sung (Jinju-shi Health Center) ;
  • Ha, Yong-Chan (Department of Orthopaedic Surgery, Chung-Ang University College of Medicine)
  • Received : 2016.09.06
  • Accepted : 2016.10.24
  • Published : 2017.02.10

Abstract

This prospective intervention study was undertaken to estimate the prevalence and treatment rate of osteoporosis following osteoporosis screening tests in the same cohort. From November 1, 2014 to August 31, 2015, participants received screening tests for osteoporosis using ultrasound bone densitometry and education concerning osteoporosis and related conditions. The participants were interviewed using a questionnaire on the diagnosis and initiation of osteoporosis treatment during the follow-up period. Of 960 potential participants, 595 people (68.8%; 150 men and 445 women) were given bone densitometry measurements and completed the questionnaire. The mean age of the participants was 74.0 years. Of the 595 participants, 393 people (66.1%; 67 men and 326 woman) were diagnosed with osteoporosis (T score < -2.5). The prevalence of osteoporosis showed an increasing trend, from 48.1% in 2004 to 66.1% in 2015. Of the 393 participants diagnosed with osteoporosis, 65 participants received additional bone densitometry measurements while hospitalized and osteoporosis management was reinitiated in 44 patients. The osteoporosis management rate in the study cohort increased from 21.6% to 32.8%, with osteoporosis diagnosed in 66.2% of participants at the latest follow-up. This prospective intervention study demonstrated that a screening test and an educational brochure increased the treatment rate from 21.6% to 32.8%.

Acknowledgement

Supported by : Korea Health Industry Development Institute (KHIDI)

References

  1. Choi HJ, Shin CS, Ha YC, Jang S, Jang S, Park C, Yoon HK, Lee SS. Burden of osteoporosis in adults in Korea: a national health insurance database study. J Bone Miner Metab 2012; 30: 54-8. https://doi.org/10.1007/s00774-011-0280-x
  2. Lee SR, Ha YC, Kang H, Park YG, Nam KW, Kim SR. Morbidity and mortality in Jeju residents over 50-years of age with hip fracture with mean 6-year follow-up: a prospective cohort study. J Korean Med Sci 2013; 28: 1089-94. https://doi.org/10.3346/jkms.2013.28.7.1089
  3. Yoon HK, Park C, Jang S, Jang S, Lee YK, Ha YC. Incidence and mortality following hip fracture in Korea. J Korean Med Sci 2011; 26: 1087-92. https://doi.org/10.3346/jkms.2011.26.8.1087
  4. Choi YJ, Oh HJ, Kim DJ, Lee Y, Chung YS. The prevalence of osteoporosis in Korean adults aged 50 years or older and the higher diagnosis rates in women who were beneficiaries of a national screening program: the Korea National Health and Nutrition Examination Survey 2008-2009. J Bone Miner Res 2012; 27: 1879-86. https://doi.org/10.1002/jbmr.1635
  5. Kanis JA, McCloskey EV, Johansson H, Cooper C, Rizzoli R, Reginster JY; Scientific Advisory Board of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the Committee of Scientific Advisors of the International Osteoporosis Foundation (IOF). European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int 2013; 24: 23-57. https://doi.org/10.1007/s00198-012-2074-y
  6. Bessette L, Ste-Marie LG, Jean S, Davison KS, Beaulieu M, Baranci M, Bessant J, Brown JP. The care gap in diagnosis and treatment of women with a fragility fracture. Osteoporos Int 2008; 19: 79-86. https://doi.org/10.1007/s00198-007-0426-9
  7. Giangregorio L, Papaioannou A, Cranney A, Zytaruk N, Adachi JD. Fragility fractures and the osteoporosis care gap: an international phenomenon. Semin Arthritis Rheum 2006; 35: 293-305. https://doi.org/10.1016/j.semarthrit.2005.11.001
  8. Hiligsmann M, Salas M, Hughes DA, Manias E, Gwadry-Sridhar FH, Linck P, Cowell W. Interventions to improve osteoporosis medication adherence and persistence: a systematic review and literature appraisal by the ISPOR Medication Adherence & Persistence Special Interest Group. Osteoporos Int 2013; 24: 2907-18. https://doi.org/10.1007/s00198-013-2364-z
  9. Sale JE, Beaton D, Posen J, Elliot-Gibson V, Bogoch E. Systematic review on interventions to improve osteoporosis investigation and treatment in fragility fracture patients. Osteoporos Int 2011; 22: 2067-82. https://doi.org/10.1007/s00198-011-1544-y
  10. Laliberte MC, Perreault S, Jouini G, Shea BJ, Lalonde L. Effectiveness of interventions to improve the detection and treatment of osteoporosis in primary care settings: a systematic review and meta-analysis. Osteoporos Int 2011; 22: 2743-68. https://doi.org/10.1007/s00198-011-1557-6
  11. Little EA, Eccles MP. A systematic review of the effectiveness of interventions to improve post-fracture investigation and management of patients at risk of osteoporosis. Implement Sci 2010; 5: 80. https://doi.org/10.1186/1748-5908-5-80
  12. Gleeson T, Iversen MD, Avorn J, Brookhart AM, Katz JN, Losina E, May F, Patrick AR, Shrank WH, Solomon DH. Interventions to improve adherence and persistence with osteoporosis medications: a systematic literature review. Osteoporos Int 2009; 20: 2127-34. https://doi.org/10.1007/s00198-009-0976-0
  13. Kendrick D, Kumar A, Carpenter H, Zijlstra GA, Skelton DA, Cook JR, Stevens Z, Belcher CM, Haworth D, Gawler SJ, et al. Exercise for reducing fear of falling in older people living in the community. Cochrane Database Syst Rev 2014: CD009848.
  14. Black DM, Reid IR, Boonen S, Bucci-Rechtweg C, Cauley JA, Cosman F, Cummings SR, Hue TF, Lippuner K, Lakatos P, et al. The effect of 3 versus 6 years of zoledronic acid treatment of osteoporosis: a randomized extension to the HORIZON-Pivotal Fracture Trial (PFT). J Bone Miner Res 2012; 27: 243-54. https://doi.org/10.1002/jbmr.1494
  15. Delmas PD. Treatment of postmenopausal osteoporosis. Lancet 2002; 359: 2018-26. https://doi.org/10.1016/S0140-6736(02)08827-X
  16. Hochberg MC, Thompson DE, Black DM, Quandt SA, Cauley J, Geusens P, Ross PD, Baran D; FIT Research Group. Effect of alendronate on the age-specific incidence of symptomatic osteoporotic fractures. J Bone Miner Res 2005; 20: 971-6. https://doi.org/10.1359/JBMR.050104
  17. Ha YC, Chun HJ, Hwang HK, Kim BS, Kim JR. The prevalence, awareness, treatment, and control of hypertension, and related factors in rural Korea. Korean J Prev Med 2000; 33: 513-20.
  18. Ha YC, Lee JS, An SH, Ham JR, Na JB, Kim JR, Kim BS, Kim SY. An epidemiological study of osteoporosis in Ibansung-meon, Jinju, by using quantitative ultrasound. Korean J Bone Metab 2005; 12: 217-23.
  19. Heyworth L, Kleinman K, Oddleifson S, Bernstein L, Frampton J, Lehrer M, Salvato K, Weiss TW, Simon SR, Connelly M. Comparison of interactive voice response, patient mailing, and mailed registry to encourage screening for osteoporosis: a randomized controlled trial. Osteoporos Int 2014; 25: 1519-26. https://doi.org/10.1007/s00198-014-2629-1
  20. Yuksel N, Majumdar SR, Biggs C, Tsuyuki RT. Community pharmacist-initiated screening program for osteoporosis: randomized controlled trial. Osteoporos Int 2010; 21: 391-8. https://doi.org/10.1007/s00198-009-0977-z
  21. Cook PF, Emiliozzi S, McCabe MM. Telephone counseling to improve osteoporosis treatment adherence: an effectiveness study in community practice settings. Am J Med Qual 2007; 22: 445-56. https://doi.org/10.1177/1062860607307990
  22. Lafata JE, Kolk D, Peterson EL, McCarthy BD, Weiss TW, Chen YT, Muma BK. Improving osteoporosis screening: results from a randomized cluster trial. J Gen Intern Med 2007; 22: 346-51. https://doi.org/10.1007/s11606-006-0060-9
  23. Elliott ME, Meek PD, Kanous NL, Schill GR, Weinswig PA, Bohlman JP, Zimpel CL, Jensen BC, Walters DR, Sutter SL, et al. Pharmacy-based bone mass measurement to assess osteoporosis risk. Ann Pharmacother 2002; 36: 571-7. https://doi.org/10.1345/aph.1A299
  24. Goode JV, Swiger K, Bluml BM. Regional osteoporosis screening, referral, and monitoring program in community pharmacies: findings from project ImPACT: osteoporosis. J Am Pharm Assoc (2003) 2004; 44: 152-60. https://doi.org/10.1331/154434504773062609
  25. Naunton M, Peterson GM, Jones G. Pharmacist-provided quantitative heel ultrasound screening for rural women at risk of osteoporosis. Ann Pharmacother 2006; 40: 38-44. https://doi.org/10.1345/aph.1G208
  26. Ahlborg HG, Rosengren BE, Jarvinen TL, Rogmark C, Nilsson JA, Sernbo I, Karlsson MK. Prevalence of osteoporosis and incidence of hip fracture in women--secular trends over 30 years. BMC Musculoskelet Disord 2010; 11: 48. https://doi.org/10.1186/1471-2474-11-48
  27. Gluer CC; The International Quantitative Ultrasound Consensus Group. Quantitative ultrasound techniques for the assessment of osteoporosis: expert agreement on current status. J Bone Miner Res 1997; 12: 1280-8. https://doi.org/10.1359/jbmr.1997.12.8.1280